CD276 as a novel CAR NK‐92 therapeutic target for neuroblastoma-Reference-Cited by-同舟云学术

CD276 as a novel CAR NK‐92 therapeutic target for neuroblastoma

Published:2020-11 Issue:1 Volume:4 Page:
ISSN:2573-8461
Container-title:ADVANCES IN CELL AND GENE THERAPY
language:en
Short-container-title:Adv Cell Gene Ther

Author:

Grote Stefan¹^ORCID,Chan Kenneth Chun‐Ho¹,Baden Caroline¹,Bösmüller Hans²,Sulyok Mihály²,Frauenfeld Leonie²,Ebinger Martin¹,Handgretinger Rupert¹,Schleicher Sabine¹^ORCID

Affiliation:

1. Department of Hematology/Oncology Children's University Hospital Tuebingen Tuebingen Germany

2. Institute of Pathology University Hospital Tuebingen Tuebingen Germany

Publisher

Hindawi Limited

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acg2.105

Reference86 articles.

1. Recent Advances in Neuroblastoma

2. Neuroblastoma

3. Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group database

4. Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

5. Advances in Risk Classification and Treatment Strategies for Neuroblastoma

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncolytic virotherapy augments self-maintaining natural killer cell line cytotoxicity against neuroblastoma;Cancer Immunology, Immunotherapy;2024-09-05

2. New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3;Vaccines;2024-01-05

3. An AI‐assisted integrated, scalable, single‐cell phenomic‐transcriptomic platform to elucidate intratumor heterogeneity against immune response;Bioengineering & Translational Medicine;2024-01-02

4. Chimeric antigen receptor engineered natural killer cells for cancer therapy;Experimental Hematology & Oncology;2023-08-10

5. Analysis of NK-92 cytotoxicity in nasopharyngeal carcinoma cell lines and patient-derived xenografts using impedance-based growth method;Heliyon;2023-07